E Fund Management’s Evommune Inc EVMN Stock Holding History

E Fund Management’s Portfolio EVMN Stock Details EVMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-243,700	Closed	-$5.6M	–	522
2026 Q1	$5.6M	Buy	+243,700	New	+$5.51M	0.17%	77

Other funds holding EVMN

EFM

EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PBPIA

Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Andera Partners Paris $206M AUM

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

E Fund Management's EVMN Position: Q2 2026 in Review

E Fund Management sold out of Evommune Inc (EVMN) in Q2 2026, closing a stake of 243,700 shares — an estimated $5.6M sold.

E Fund Management first reported a position in EVMN in Q1 2026 and held it in 1 quarter. The position peaked at $5.6M in Q1 2026. 105 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

E Fund Management reported no remaining Evommune Inc position as of Q2 2026 after selling out during the quarter.
E Fund Management sold 243,700 Evommune Inc shares in Q2 2026, an estimated $5.6M.
E Fund Management first reported a position in Evommune Inc in Q1 2026 and held it in 1 quarter.
E Fund Management's Evommune Inc position peaked at $5.6M in Q1 2026.
105 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.